Paul D. Dobson

4.8k total citations
24 papers, 1.9k citations indexed

About

Paul D. Dobson is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Paul D. Dobson has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Paul D. Dobson's work include Microbial Metabolic Engineering and Bioproduction (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Paul D. Dobson is often cited by papers focused on Microbial Metabolic Engineering and Bioproduction (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Paul D. Dobson collaborates with scholars based in United Kingdom, Japan and United States. Paul D. Dobson's co-authors include Douglas B. Kell, Andrew J. Doig, Stephen G. Oliver, Yogendra Patel, Elizabeth Bilsland, Neil Swainston, Karin Lanthaler, Warwick B. Dunn, Glenn Reeves and M Loewenthal and has published in prestigious journals such as Bioinformatics, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Paul D. Dobson

24 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul D. Dobson United Kingdom 18 1.2k 302 290 268 159 24 1.9k
Qingxia Yang China 25 1.9k 1.6× 496 1.6× 156 0.5× 156 0.6× 268 1.7× 59 2.8k
Ina Koch Germany 26 2.1k 1.8× 325 1.1× 373 1.3× 181 0.7× 66 0.4× 107 3.3k
Sutisak Kitareewan United States 13 2.4k 2.1× 89 0.3× 358 1.2× 322 1.2× 82 0.5× 20 3.2k
Paolo Magni Italy 27 986 0.8× 175 0.6× 397 1.4× 200 0.7× 136 0.9× 136 2.4k
Rengül Çetin-Atalay Türkiye 33 2.0k 1.8× 670 2.2× 358 1.2× 140 0.5× 64 0.4× 140 3.8k
Brian Kelley United States 25 1.9k 1.6× 1.5k 4.9× 139 0.5× 157 0.6× 153 1.0× 61 3.6k
Neema Jamshidi United States 32 2.8k 2.4× 215 0.7× 273 0.9× 76 0.3× 84 0.5× 71 4.0k
Amitabh Sharma United States 22 1.9k 1.7× 546 1.8× 181 0.6× 170 0.6× 39 0.2× 38 3.0k
Qi Liu China 31 2.6k 2.2× 535 1.8× 392 1.4× 144 0.5× 54 0.3× 137 3.6k

Countries citing papers authored by Paul D. Dobson

Since Specialization
Citations

This map shows the geographic impact of Paul D. Dobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Dobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Dobson more than expected).

Fields of papers citing papers by Paul D. Dobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Dobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Dobson. The network helps show where Paul D. Dobson may publish in the future.

Co-authorship network of co-authors of Paul D. Dobson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Dobson. A scholar is included among the top collaborators of Paul D. Dobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Dobson. Paul D. Dobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swainston, Neil, Riza Batista-Navarro, Pablo Carbonell, et al.. (2017). biochem4j: Integrated and extensible biochemical knowledge through graph databases. PLoS ONE. 12(7). e0179130–e0179130. 26 indexed citations
2.
Kell, Douglas B., Paul D. Dobson, Elizabeth Bilsland, & Stephen G. Oliver. (2012). The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discovery Today. 18(5-6). 218–239. 102 indexed citations
3.
Lanthaler, Karin, Elizabeth Bilsland, Paul D. Dobson, et al.. (2011). Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast. BMC Biology. 9(1). 70–70. 53 indexed citations
4.
Kell, Douglas B., Paul D. Dobson, & Stephen G. Oliver. (2011). Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discovery Today. 16(15-16). 704–714. 139 indexed citations
5.
Dobson, Paul D., Kieran Smallbone, Daniel Jameson, et al.. (2010). Further developments towards a genome-scale metabolic model of yeast. BMC Systems Biology. 4(1). 145–145. 82 indexed citations
6.
Kano, Yoshinobu, Paul D. Dobson, Mio Nakanishi, Jun’ichi Tsujii, & Sophia Ananiadou. (2010). Text mining meets workflow: linking U-Compare with Taverna. Bioinformatics. 26(19). 2486–2487. 14 indexed citations
7.
Nobata, Chikashi, Paul D. Dobson, Syed Amir Iqbal, et al.. (2010). Mining metabolites: extracting the yeast metabolome from the literature. Metabolomics. 7(1). 94–101. 35 indexed citations
8.
Tsuruoka, Yoshimasa, et al.. (2010). Integration of metabolic databases for the reconstruction of genome-scale metabolic networks. BMC Systems Biology. 4(1). 114–114. 70 indexed citations
9.
Dobson, Paul D., Karin Lanthaler, Stephen G. Oliver, & Douglas B. Kell. (2009). Implications of the Dominant Role of Transporters in Drug Uptake by Cells (Supplementary Material). Current Topics in Medicinal Chemistry. 9(2). 163–181. 68 indexed citations
10.
Brown, Martin, Warwick B. Dunn, Paul D. Dobson, et al.. (2009). Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. The Analyst. 134(7). 1322–1322. 195 indexed citations
11.
Kell, Douglas B. & Paul D. Dobson. (2009). The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology. Research Explorer (The University of Manchester). 149–168. 19 indexed citations
12.
Dobson, Paul D., Yogendra Patel, & Douglas B. Kell. (2008). ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discovery Today. 14(1-2). 31–40. 105 indexed citations
13.
Dobson, Paul D. & Douglas B. Kell. (2008). Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nature Reviews Drug Discovery. 7(3). 205–220. 350 indexed citations
14.
Qureshi, Hamna J., D. Lowe, Paul D. Dobson, et al.. (2007). National comparative audit of the use of platelet transfusions in the UK. Transfusion Clinique et Biologique. 14(6). 509–513. 47 indexed citations
15.
Dobson, Paul D. & Andrew J. Doig. (2004). Predicting Enzyme Class From Protein Structure Without Alignments. Journal of Molecular Biology. 345(1). 187–199. 122 indexed citations
16.
Reeves, Glenn, et al.. (2004). Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Internal Medicine Journal. 34(4). 182–186. 84 indexed citations
17.
Dobson, Paul D., Yu‐Dong Cai, Benjamin J. Stapley, & Andrew J. Doig. (2004). Prediction of Protein Function in the Absence of Significant Sequence Similarity. Current Medicinal Chemistry. 11(16). 2135–2142. 48 indexed citations
18.
Dobson, Paul D. & Andrew J. Doig. (2003). Distinguishing Enzyme Structures from Non-enzymes Without Alignments. Journal of Molecular Biology. 330(4). 771–783. 335 indexed citations
19.
Dobson, Paul D.. (1973). Urinary incontinence. Social aspects.. PubMed. 59(11). 358–9. 1 indexed citations
20.
Dobson, Paul D.. (1972). MANAGEMENT OF INCONTINENCE IN THE HOME. PubMed Central. 22(121). 541–541. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingxia Yang Breakdown of academic impact, for papers by Ina Koch Breakdown of academic impact, for papers by Sutisak Kitareewan Breakdown of academic impact, for papers by Paolo Magni Breakdown of academic impact, for papers by Rengül Çetin-Atalay Breakdown of academic impact, for papers by Brian Kelley Breakdown of academic impact, for papers by Neema Jamshidi Breakdown of academic impact, for papers by Amitabh Sharma Breakdown of academic impact, for papers by Qi Liu
Rankless by CCL
2026